article thumbnail

FDA Issues Guidance on Clinical Pharmacology for Peptide Drugs

PharmaTech

The guidance document discusses the impact of clinical pharmacology considerations on peptide drug development.

article thumbnail

As Viatris seeks growth in eye care, its Ocuphire-partnered dilation drop Ryzumvi wins FDA nod

Fierce Pharma

The FDA on Wednesday approved Viatris and Ocuphire’s Ryzumvi, also known as phentolamine ophthalmic solution, to treat pharmacologically-induced mydriasis, or dilation of the pupils. Viatris just notched a win on its quest to reach $1 billion in eye care sales by 2028. | The partners plan to make Ryzumvi available in the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Moving Beyond Medicine To Treat Chronic Pain

MedCity News

I look at non-pharmacological approaches like digital therapeutics as having the potential to give someone like me living with chronic pain everything I need to make a healthy recovery: access to digital treatments and clinicians, to community, coaching, and navigation services.

article thumbnail

FDA Issues Guidance on CAR-T Cell Product Development

PharmaTech

The final guidance provides specific recommendations for CMC, pharmacology, toxicology, and clinical study design for CAR-T cell products.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

In this exclusive webinar, Dr. Ben Locwin will discuss the potential effects of this draft, along with the pharmacological and toxicological considerations for optimizing doses of prescription drugs.

article thumbnail

Klotho : A hope for the acute kidney injury-diabetes comorbidity

Pharmatutor

Laboratory of Molecular Pharmacology, Department of Pharmacy, Birla Institute of Technology and Science Pilani, Pilani Campus, Rajasthan, India. Klotho : A hope for the acute kidney injury-diabetes comorbidity. Thu, 11/24/2022 - 10:12. About Authors. Ajinath Kale, Anil Bhanudas Gaikwad*. anil.gaikwad@pilani.bits-pilani.ac.in.

article thumbnail

With overdoses skyrocketing, Congress must consider non-opioid alternatives to pain management

MedCity News

Yet, they are too often overlooked by Congress and a healthcare system that tends to default to pharmacological treatments as the first step in pain reduction. Complementary and integrative healthcare providers, including chiropractic physicians, acupuncturists, and massage therapists, provide effective and safe treatments for pain.